Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy

Bryant, 2013, Improving medication adherence in chronic obstructive pulmonary disease: a systematic review, Respir Res, 14, 109, 10.1186/1465-9921-14-109 Toy, 2011, Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs, Respir Med, 105, 435, 10.1016/j.rmed.2010.09.006 Thomas, 2015, Why aren't we doing better in asthma: time for personalised medicine?, NPJ Prim Care Respir Med, 25, 15004, 10.1038/npjpcrm.2015.4 Mäkelä, 2013, Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD, Respir Med, 107, 1481, 10.1016/j.rmed.2013.04.005 Cramer, 2008, Medication compliance and persistence: terminology and definitions, Value Health, 11, 44, 10.1111/j.1524-4733.2007.00213.x Caetano, 2006, Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization, Clin Ther, 28, 1411, 10.1016/j.clinthera.2006.09.021 Vanelli, 2009, The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses, Clin Ther, 31, 2628, 10.1016/j.clinthera.2009.11.028 Bender, 2006, Adherence and persistence with fluticasone propionate/salmeterol combination therapy, J Allergy Clin Immunol, 118, 899, 10.1016/j.jaci.2006.07.002 Virchow, 2014, Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study, Expert Opin Drug Deliv, 11, 1849, 10.1517/17425247.2014.949236 Peterson, 2007, A checklist for medication compliance and persistence studies using retrospective databases, Value Health, 10, 3, 10.1111/j.1524-4733.2006.00139.x Li, 2016, Statistical inference methods for two crossing survival curves: a comparison of methods, PLoS One, 10, e0116774, 10.1371/journal.pone.0116774 Lavorini, 2015, Asthma and COPD: interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR), Pulm Pharmacol Ther, 34, 25, 10.1016/j.pupt.2015.07.005 Darbà, 2015, The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients, Int J Chorn Obstruct Pulmon Dis, 10, 2335, 10.2147/COPD.S90155 Hasford, 2010, Persistence with asthma treatment is low in Germany especially for controller medication—a population based study of 483 051 patients, Allergy, 65, 347, 10.1111/j.1398-9995.2009.02161.x Kreis, 2016, Status and perspectives of claims data analyses in Germany—a systematic review, Health Policy, 120, 213, 10.1016/j.healthpol.2016.01.007 García Rodríguez, 1998, Use of the UK General Practice Research Database for pharmacoepidemiology, Br J Clin Pharmacol, 45, 419, 10.1046/j.1365-2125.1998.00701.x Penning-van Beest, 2011, Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis, Respir Med, 105, 259, 10.1016/j.rmed.2010.07.007 Barnes, 2015, Asthma and adherence to inhaled corticosteroids: current status and future perspectives, Respir Care, 60, 455, 10.4187/respcare.03200 Cramer, 2007, Treatment persistence and compliance with medications for chronic obstructive pulmonary disease, Can Respir J, 14, 25, 10.1155/2007/161652 Bender, 2013, Advancing the science of adherence measurement: implications for the clinician, J Allergy Clin Immunol Pract, 1, 92, 10.1016/j.jaip.2012.10.007 Antoniu, 2010, Adherence to inhaled therapy in COPD: effects on survival and exacerbations, Expert Rev Pharmacoecon Outcomes Res, 10, 115, 10.1586/erp.10.10 Lavorini, 2014, Inhaled drug delivery in the hands of the patient, J Aerosol Med Pulm Drug Deliv, 27, 414, 10.1089/jamp.2014.1132